Plasma interleukin-23 and circulating IL-17A + IFNγ + ex-Th17 cells predict opposing outcomes of anti-TNF therapy in rheumatoid arthritis.
Melanie J MillierNiamh C FanningChristopher FramptonLisa K StampPaul A HessianPublished in: Arthritis research & therapy (2022)
ex-Th17 cells provide additive value to the prediction of response to anti-TNF therapy in RA.